T-cells Leukemia Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: TE1CDDBF5F0DEN
Market Monitor Global

Abstracts

Leukemia refers to cancer of the blood cells. It occurs due to changes in the bone marrow characterized with uncontrollable growth of the blood cells.

This report contains market size and forecasts of T-cells Leukemia Treatment in Global, including the following market information:

Global T-cells Leukemia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global T-cells Leukemia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of T-cells Leukemia Treatment include BioCryst Pharmaceuticals, Celgene, GlaxoSmithKline, Kirin Holdings, Otsuka Holdings, Mundipharma International and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the T-cells Leukemia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global T-cells Leukemia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global T-cells Leukemia Treatment Market Segment Percentages, by Type, 2021 (%)

• Surgery
• Chemotherapy
• Radiation Therapy

Global T-cells Leukemia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global T-cells Leukemia Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinic
• Others

Global T-cells Leukemia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global T-cells Leukemia Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies T-cells Leukemia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies T-cells Leukemia Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BioCryst Pharmaceuticals
• Celgene
• GlaxoSmithKline
• Kirin Holdings
• Otsuka Holdings
• Mundipharma International
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 T-cells Leukemia Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global T-cells Leukemia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL T-CELLS LEUKEMIA TREATMENT OVERALL MARKET SIZE

2.1 Global T-cells Leukemia Treatment Market Size: 2021 VS 2028
2.2 Global T-cells Leukemia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top T-cells Leukemia Treatment Players in Global Market
3.2 Top Global T-cells Leukemia Treatment Companies Ranked by Revenue
3.3 Global T-cells Leukemia Treatment Revenue by Companies
3.4 Top 3 and Top 5 T-cells Leukemia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies T-cells Leukemia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 T-cells Leukemia Treatment Players in Global Market
  3.6.1 List of Global Tier 1 T-cells Leukemia Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 T-cells Leukemia Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global T-cells Leukemia Treatment Market Size Markets, 2021 & 2028
  4.1.2 Surgery
  4.1.3 Chemotherapy
  4.1.4 Radiation Therapy
4.2 By Type - Global T-cells Leukemia Treatment Revenue & Forecasts
  4.2.1 By Type - Global T-cells Leukemia Treatment Revenue, 2017-2022
  4.2.2 By Type - Global T-cells Leukemia Treatment Revenue, 2023-2028
  4.2.3 By Type - Global T-cells Leukemia Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global T-cells Leukemia Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global T-cells Leukemia Treatment Revenue & Forecasts
  5.2.1 By Application - Global T-cells Leukemia Treatment Revenue, 2017-2022
  5.2.2 By Application - Global T-cells Leukemia Treatment Revenue, 2023-2028
  5.2.3 By Application - Global T-cells Leukemia Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global T-cells Leukemia Treatment Market Size, 2021 & 2028
6.2 By Region - Global T-cells Leukemia Treatment Revenue & Forecasts
  6.2.1 By Region - Global T-cells Leukemia Treatment Revenue, 2017-2022
  6.2.2 By Region - Global T-cells Leukemia Treatment Revenue, 2023-2028
  6.2.3 By Region - Global T-cells Leukemia Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America T-cells Leukemia Treatment Revenue, 2017-2028
  6.3.2 US T-cells Leukemia Treatment Market Size, 2017-2028
  6.3.3 Canada T-cells Leukemia Treatment Market Size, 2017-2028
  6.3.4 Mexico T-cells Leukemia Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe T-cells Leukemia Treatment Revenue, 2017-2028
  6.4.2 Germany T-cells Leukemia Treatment Market Size, 2017-2028
  6.4.3 France T-cells Leukemia Treatment Market Size, 2017-2028
  6.4.4 U.K. T-cells Leukemia Treatment Market Size, 2017-2028
  6.4.5 Italy T-cells Leukemia Treatment Market Size, 2017-2028
  6.4.6 Russia T-cells Leukemia Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries T-cells Leukemia Treatment Market Size, 2017-2028
  6.4.8 Benelux T-cells Leukemia Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia T-cells Leukemia Treatment Revenue, 2017-2028
  6.5.2 China T-cells Leukemia Treatment Market Size, 2017-2028
  6.5.3 Japan T-cells Leukemia Treatment Market Size, 2017-2028
  6.5.4 South Korea T-cells Leukemia Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia T-cells Leukemia Treatment Market Size, 2017-2028
  6.5.6 India T-cells Leukemia Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America T-cells Leukemia Treatment Revenue, 2017-2028
  6.6.2 Brazil T-cells Leukemia Treatment Market Size, 2017-2028
  6.6.3 Argentina T-cells Leukemia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa T-cells Leukemia Treatment Revenue, 2017-2028
  6.7.2 Turkey T-cells Leukemia Treatment Market Size, 2017-2028
  6.7.3 Israel T-cells Leukemia Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia T-cells Leukemia Treatment Market Size, 2017-2028
  6.7.5 UAE T-cells Leukemia Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 BioCryst Pharmaceuticals
  7.1.1 BioCryst Pharmaceuticals Corporate Summary
  7.1.2 BioCryst Pharmaceuticals Business Overview
  7.1.3 BioCryst Pharmaceuticals T-cells Leukemia Treatment Major Product Offerings
  7.1.4 BioCryst Pharmaceuticals T-cells Leukemia Treatment Revenue in Global Market (2017-2022)
  7.1.5 BioCryst Pharmaceuticals Key News
7.2 Celgene
  7.2.1 Celgene Corporate Summary
  7.2.2 Celgene Business Overview
  7.2.3 Celgene T-cells Leukemia Treatment Major Product Offerings
  7.2.4 Celgene T-cells Leukemia Treatment Revenue in Global Market (2017-2022)
  7.2.5 Celgene Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline T-cells Leukemia Treatment Major Product Offerings
  7.3.4 GlaxoSmithKline T-cells Leukemia Treatment Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Kirin Holdings
  7.4.1 Kirin Holdings Corporate Summary
  7.4.2 Kirin Holdings Business Overview
  7.4.3 Kirin Holdings T-cells Leukemia Treatment Major Product Offerings
  7.4.4 Kirin Holdings T-cells Leukemia Treatment Revenue in Global Market (2017-2022)
  7.4.5 Kirin Holdings Key News
7.5 Otsuka Holdings
  7.5.1 Otsuka Holdings Corporate Summary
  7.5.2 Otsuka Holdings Business Overview
  7.5.3 Otsuka Holdings T-cells Leukemia Treatment Major Product Offerings
  7.5.4 Otsuka Holdings T-cells Leukemia Treatment Revenue in Global Market (2017-2022)
  7.5.5 Otsuka Holdings Key News
7.6 Mundipharma International
  7.6.1 Mundipharma International Corporate Summary
  7.6.2 Mundipharma International Business Overview
  7.6.3 Mundipharma International T-cells Leukemia Treatment Major Product Offerings
  7.6.4 Mundipharma International T-cells Leukemia Treatment Revenue in Global Market (2017-2022)
  7.6.5 Mundipharma International Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis T-cells Leukemia Treatment Major Product Offerings
  7.7.4 Novartis T-cells Leukemia Treatment Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. T-cells Leukemia Treatment Market Opportunities & Trends in Global Market
Table 2. T-cells Leukemia Treatment Market Drivers in Global Market
Table 3. T-cells Leukemia Treatment Market Restraints in Global Market
Table 4. Key Players of T-cells Leukemia Treatment in Global Market
Table 5. Top T-cells Leukemia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global T-cells Leukemia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global T-cells Leukemia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies T-cells Leukemia Treatment Product Type
Table 9. List of Global Tier 1 T-cells Leukemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-cells Leukemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global T-cells Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - T-cells Leukemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - T-cells Leukemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global T-cells Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - T-cells Leukemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - T-cells Leukemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global T-cells Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global T-cells Leukemia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global T-cells Leukemia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America T-cells Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe T-cells Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia T-cells Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America T-cells Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa T-cells Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. BioCryst Pharmaceuticals Corporate Summary
Table 31. BioCryst Pharmaceuticals T-cells Leukemia Treatment Product Offerings
Table 32. BioCryst Pharmaceuticals T-cells Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporate Summary
Table 34. Celgene T-cells Leukemia Treatment Product Offerings
Table 35. Celgene T-cells Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline T-cells Leukemia Treatment Product Offerings
Table 38. GlaxoSmithKline T-cells Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Kirin Holdings Corporate Summary
Table 40. Kirin Holdings T-cells Leukemia Treatment Product Offerings
Table 41. Kirin Holdings T-cells Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Otsuka Holdings Corporate Summary
Table 43. Otsuka Holdings T-cells Leukemia Treatment Product Offerings
Table 44. Otsuka Holdings T-cells Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Mundipharma International Corporate Summary
Table 46. Mundipharma International T-cells Leukemia Treatment Product Offerings
Table 47. Mundipharma International T-cells Leukemia Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis T-cells Leukemia Treatment Product Offerings
Table 50. Novartis T-cells Leukemia Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. T-cells Leukemia Treatment Segment by Type in 2021
Figure 2. T-cells Leukemia Treatment Segment by Application in 2021
Figure 3. Global T-cells Leukemia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global T-cells Leukemia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global T-cells Leukemia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by T-cells Leukemia Treatment Revenue in 2021
Figure 8. By Type - Global T-cells Leukemia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global T-cells Leukemia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global T-cells Leukemia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America T-cells Leukemia Treatment Revenue Market Share, 2017-2028
Figure 12. US T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe T-cells Leukemia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia T-cells Leukemia Treatment Revenue Market Share, 2017-2028
Figure 24. China T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America T-cells Leukemia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa T-cells Leukemia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE T-cells Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. BioCryst Pharmaceuticals T-cells Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene T-cells Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline T-cells Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Kirin Holdings T-cells Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Otsuka Holdings T-cells Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mundipharma International T-cells Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis T-cells Leukemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)